| 1031 |
Intravenous Thrombolysis in Patients With Recent Intake of Direct Oral Anticoagulants: A Target Trial Analysis and Comparison With Reversal Agent Use
|
2025-07-30 |
41 |
| 1030 |
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
|
2025-07-30 |
40 |
| 1029 |
Intravenous Tenecteplase before Thrombectomy in Stroke
|
2025-07-30 |
46 |
| 1028 |
Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial
|
2025-06-30 |
182 |
| 1027 |
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials
|
2025-06-30 |
150 |
| 1026 |
Optimal Head-of-Bed Positioning Before Thrombectomy in Stroke
|
2025-06-30 |
135 |
| 1025 |
MRI Predictors of Cognitive Function After Lacunar Infarction
|
2025-05-27 |
257 |
| 1024 |
Extended CT angiography versus standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): a prospective, randomised, open-label, blinded end-point trial
|
2025-05-27 |
270 |
| 1023 |
Intravenous Tenecteplase before Thrombectomy in Stroke
|
2025-05-27 |
260 |
| 1022 |
Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results
|
2025-04-30 |
395 |
| 1021 |
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial
|
2025-04-30 |
332 |
| 1020 |
Acute Blood Pressure Lowering and Risk of Ischemic Lesions on MRI After Intracerebral Hemorrhage
|
2025-04-30 |
330 |
| 1019 |
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
|
2025-03-31 |
415 |
| 1018 |
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
|
2025-03-31 |
418 |
| 1017 |
Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study
|
2025-03-31 |
486 |
HOME
LOGIN
